Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain
Authors Nicole Rae Yurgin, Kristina Secnik Boye, Tatiana Dilla, Núria Lara Suriñach, Xavier Badia Llach
Published 8 April 2008 Volume 2008:2 Pages 87—95
Nicole Rae Yurgin1, Kristina Secnik Boye1, Tatiana Dilla2, Núria Lara Suriñach3, Xavier Badia Llach3
1Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly and Company, Spain; 3HEOR, IMS Health, Spain
Abstract: The objective of this study was to assess current treatment patterns, blood glucose test strip usage, and treatment compliance in patients with type 2 diabetes mellitus (T2DM) in primary care centers in Spain, and to assess factors related to glycemic control. We conducted a retrospective chart review of patients with T2DM and measured treatment compliance using the Morisky-Green questionnaire. 294 patients were included in the study from a population of patients attending 30 primary care centers throughout Spain. Results showed that the majority of patients were treated with oral monotherapy (36%) and oral combination therapy (35%). Less than half of the patients had good glycemic control (HbA1c ≤ 6.5%). Half of the patients treated pharmacologically reported good compliance with treatment. Logistic regression analyses performed to identify factors associated with glycemic control showed that high body mass index (BMI) and poor compliance were the strongest predictors of poor HbA1c control (OR: 2.198 and 1.789, respectively, p < 0.05). In conclusion, in the course of managing diabetes, physicians and patients should attempt to improve compliance and lower BMI, which could lead to better glycemic control.
Keywords: treatment adherence, treatment pattern, glucose control, diabetes, primary care